webinar register page

Webinar banner
The Cancer Fight: Advancements in Immunotherapy
The fight is on!

Jefferson is at the forefront of research and clinical trials utilizing immunotherapy treatments to amplify results in the fight against cancer cells. Join physicians Babar Bashir, MD, assistant professor in Medical Oncology, and Adam Luginbuhl, MD ’12, associate professor and director of Medical Student Education, as they discuss the discoveries and advancements in their work and its impact on the patients in treatment.

May 6, 2020 07:00 PM in Eastern Time (US and Canada)

* Required information
Loading

Speakers

Babar Bashir, MD
Assistant Professor, Department of Medical Oncology @Thomas Jefferson University
Babar Bashir, MD, is an assistant professor with a primary appointment in the Department of Medical Oncology and a secondary appointment in the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University. He has significant and relevant experience in translational cancer research, and his laboratory research is focused on defining the pathophysiology of silencing of tumor suppressors in colorectal neoplasms.
Adam Luginbuhl, MD ’12
Associate Professor, Department of Otolaryngology-HNS @Thomas Jefferson University
Adam Luginbuhl, MD ’12, received his MD at the University of Connecticut School of Medicine in 2007. He completed his residency in Otolaryngology – Head and Neck Surgery at Thomas Jefferson University in 2012. He completed his fellowship training in Advanced Head and Neck Oncologic Surgery at Vanderbilt University in 2013. Dr. Luginbuhl joined Jefferson’s Department of Otolaryngology-HNS in 2013 and quickly advanced to associate professor. He specializes in the care of patients with benign and malignant tumors of the head and neck. His advanced training includes endoscopic laser techniques for organ-preserving management of laryngeal cancer, as well as minimally-invasive approaches for thyroid and parathyroid surgery. His expertise covers all aspects of the management of head and neck cancer.